EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligand.
Neuro-Oncology Advances
Hoogstrate, Youri Y; Vallentgoed, Wies W; Kros, Johan M JM; de Heer, Iris I; de Wit, Maurice M; Eoli, Marica M; Sepulveda, Juan Manuel JM; Walenkamp, Annemiek M E AME; Frenel, Jean-Sebastien JS; Franceschi, Enrico E; Clement, Paul M PM; Weller, Micheal M; van Royen, Martin E ME; Ansell, Peter P; Looman, Jim J; Bain, Earle E; Morfouace, Marie M; Gorlia, Thierry T; Golfinopoulos, Vassilis V; van den Bent, Martin M; French, Pim J PJ